PATHFAST cTnI-II Test Receives 510(k) Clearance
Mitsubishi Chemical Medience Corp announced that the FDA has granted 510(k) premarketing notification clearance to the PATHFAST cTnI-II (cardiac Troponin I) diagnostic test
Read MoreSearch Results for: point-of-care
Avantra Offers Rapid Assay Prototyping Service
Posted by Clinical Lab Products | Jun 7, 2011 | Miscellaneous, POC Rapid Assays |
The company’s new service allows researchers to accelerate their research efforts using custom designed biomarker assays developed on Avantra’s QPDx BioChip platform.
Read MoreChembio to Participate in, Sponsor AIDS Walk New York 2011
Posted by Clinical Lab Products | May 12, 2011 | Miscellaneous |
Not only is Chembio among the walk’s sponsors, company employees will also be participating in this historic walk to raise funds for AIDS research.
Read MoreAkonni, Seegene Enter Nonexclusive Licensing Agreement
Posted by Clinical Lab Products | May 9, 2011 | Cancer, Miscellaneous |
The agreement brings together Seegene’s Dual Priming Oligo multiplex PCR technology and Akonni’s TruArray gel-drop microarray technology.
Read MoreBio-Manguinhos to Market Chembio Solution in Brazil
Posted by Clinical Lab Products | May 6, 2011 | Miscellaneous |
Bio-Manguinhos has received regulatory approval from Brazil’s National Health Surveillance Agency to market Chembio’s Dual Path Platform Syphilis Treponemal test.
Read More